Blackbaud Newsroom

Target Analytics Launches New Specialized Fundraising Solutions

New Grateful Patient solution for hospitals and Very Important Patron solution
for arts and cultural organizations to improve prospecting and fundraising results

Charleston, S.C. (October 13, 2015) — Target Analytics, a division of Blackbaud, Inc. (NASDAQ: BLKB), today announced the availability of its Grateful Patient Healthcare solution, designed for patient populations, and Very Important Patron (VIP) solution, specific to arts & cultural visitor and ticket buyer populations, enabling rapid identification of donor prospects for annual gift and major gift fundraising appeals.

“Both healthcare and arts & cultural organizations have diverse daily visitors, all of which are meaningfully engaged in an experiential event, but only a select number have the likelihood and capacity to honor that experience with a philanthropic gift,” said Richard Becker, president of Blackbaud Target Analytics. “Our new screening solutions enable both healthcare and arts and cultural organizations to identify annual and major gift fundraising prospects when visitors are meaningfully engaged with their organization, increasing fundraising opportunity identification, effectiveness and donor conversion.”

Target Analytics’ Grateful Patient Healthcare solution
Healthcare organizations create grateful patients on a daily basis, and many of these grateful patients possess philanthropic characteristics that make them prime candidates for an annual or major gift. With Target Analytics’ Grateful Patient Healthcare solution, healthcare organizations can screen lists of in-patient and out-patient files within minutes, obtaining information that identifies and prioritizes donor prospects from recent patient populations, along with intelligence that influences donor prospect engagement, whether that engagement is via direct marketing or face-to-face.

“The healthcare bundle is having a major impact on our daily processes and, more specifically, refining our Grateful Patient program. Our development officers are more fully equipped to meet their day-to-day and annual goals,” said Cherie Menke, system development data coordinator for UCHealth.

Target Analytics’ Very Important Patron (VIP) solution
Arts & cultural organizations engage patrons with performances, exhibitions, and events, providing them culturally rich learning and life experiences. Many of these patrons have demonstrated philanthropic behaviors and wealth characteristics that make them uniquely qualified to give an annual or major gift. With Target Analytics’ Very Important Patron (VIP) solution, arts & cultural organizations can screen lists of visitors and participants within minutes, obtaining key data that enables the identification and prioritization of donor prospects, along with information that enables a timely direct marketing or major gift fundraising strategy.

“By far – Target Analytics gives us the best results, and better accuracy in matching donors with the wealth information available,” said Candace Chesler, Blackbaud Database Manager at Bernard Zell Anshe Emet.

Target Analytics, a division of Blackbaud Inc., offers data and analytic driven solutions to over 7,000 nonprofit clients, enabling nonprofits’ direct marketing fundraising, donor prospect research, major gift fundraising, data health, and fundraising performance measurement. For more information about its Grateful Patient Healthcare solution, visit and to learn more about its Very Important Patron (VIP) solution, visit

About Blackbaud

Serving the nonprofit, charitable giving and education communities for more than 30 years, Blackbaud (NASDAQ:BLKB) combines technology solutions and expertise to help organizations achieve their missions. Blackbaud works in over 60 countries to support more than 30,000 customers, including nonprofits, K12 private and higher education institutions, healthcare organizations, foundations and other charitable giving entities, and corporations. The company offers a full spectrum of cloud and on-premise solutions, and related services for organizations of all sizes, including nonprofit fundraising and relationship management, eMarketing, advocacy, accounting, payments and analytics, as well as grant management, corporate social responsibility, education and other solutions. Using Blackbaud technology, these organizations raise, invest, manage and award more than $100 billion each year. Recognized as a top company, Blackbaud is headquartered in Charleston, South Carolina and has operations in the United States, Australia, Canada, the Netherlands, Ireland and the United Kingdom. For more information, visit

Media Contact

Nicole McGougan
Public Relations

Forward-looking Statements
Except for historical information, all of the statements, expectations, and assumptions contained in this news release are forward-looking statements that involve a number of risks and uncertainties, including statements regarding the introduction of new products and product features, as well as the expected benefits of the new products and product features. Although Blackbaud attempts to be accurate in making these forward-looking statements, it is possible that future circumstances might differ from the assumptions on which such statements are based. In addition, other important factors that could cause results to differ materially include the following: general economic risks; uncertainty regarding increased business and renewals from existing customers; continued success in sales growth; management of integration of acquired companies and other risks associated with acquisitions; risks associated with successful implementation of multiple integrated software products; the ability to attract and retain key personnel; risks associated with management of growth; lengthy sales and implementation cycles, particularly in larger organization; technological changes that make our products and services less competitive; and the other risk factors set forth from time to time in the SEC filings for Blackbaud, copies of which are available free of charge at the SEC’s website at or upon request from Blackbaud’s investor relations department. All Blackbaud product names appearing herein are trademarks or registered trademarks of Blackbaud, Inc.